中国当代医药
中國噹代醫藥
중국당대의약
PERSON
2014年
26期
132-133,136
,共3页
晚期肿瘤%姑息治疗%生存质量%辨证论治%参附注射液
晚期腫瘤%姑息治療%生存質量%辨證論治%參附註射液
만기종류%고식치료%생존질량%변증론치%삼부주사액
Advanced cancer%Alleviative treatment%Quality of life%Syndrome differentiation and treatment%Shenfu in-jection
目的：观察参附注射液应用于脾肾阳虚晚期肿瘤患者的临床疗效。方法选取62例辨证属脾肾阳虚的晚期肿瘤患者随机分为治疗组和对照组，每组31例，对照组采用常规姑息治疗，治疗组在常规治疗上加用参附注射液静脉滴注，1个疗程后，观察并比较两组的临床症状改善情况及生活质量状况。结果治疗组的总有效率为71.0%，高于对照组的45.2%，差异有统计学意义(P<0.05)；治疗组生活质量改善率为80.6%，高于对照组的51.6%，差异有统计学意义(P<0.05)。结论辨证应用参附注射液能有效提高脾肾阳虚型晚期肿瘤患者的生活质量，改善临床症状，达到治疗目的。
目的：觀察參附註射液應用于脾腎暘虛晚期腫瘤患者的臨床療效。方法選取62例辨證屬脾腎暘虛的晚期腫瘤患者隨機分為治療組和對照組，每組31例，對照組採用常規姑息治療，治療組在常規治療上加用參附註射液靜脈滴註，1箇療程後，觀察併比較兩組的臨床癥狀改善情況及生活質量狀況。結果治療組的總有效率為71.0%，高于對照組的45.2%，差異有統計學意義(P<0.05)；治療組生活質量改善率為80.6%，高于對照組的51.6%，差異有統計學意義(P<0.05)。結論辨證應用參附註射液能有效提高脾腎暘虛型晚期腫瘤患者的生活質量，改善臨床癥狀，達到治療目的。
목적：관찰삼부주사액응용우비신양허만기종류환자적림상료효。방법선취62례변증속비신양허적만기종류환자수궤분위치료조화대조조，매조31례，대조조채용상규고식치료，치료조재상규치료상가용삼부주사액정맥적주，1개료정후，관찰병비교량조적림상증상개선정황급생활질량상황。결과치료조적총유효솔위71.0%，고우대조조적45.2%，차이유통계학의의(P<0.05)；치료조생활질량개선솔위80.6%，고우대조조적51.6%，차이유통계학의의(P<0.05)。결론변증응용삼부주사액능유효제고비신양허형만기종류환자적생활질량，개선림상증상，체도치료목적。
Objective To observe clinical effects of Shenfu injection applied in the spleen and kidney deficiency type of patients with advanced cancer. Methods 62 patients with advanced cancer of spleen and kidney deficiency type were selected and randomly divided into treatment group and control group,31 patients in each group.Alleviative treat-ment alone was used in control group and Shenfu injection combined with alleviative treatment were used in treatment group.The improvement of clinical symptom and patients’ quality of life was compared between two groups after a course of treatment respectively. Results Total effective rate in treatment group was 71.0%,higher than that in control group(45.2%),with statistical difference(P<0.05).The improvement rate in treatment group was 80.6%,higher than that in control group(51.6%),with statistical difference(P<0.05). Conclusion The dialectical application of Shenfu injection can improve the life quality of the spleen and kidney deficiency type patients with advanced cancer,relieve the clinical symptom,achieve the goal of treatment.
